None
Quote | Cerus Corporation (NASDAQ:CERS)
Last: | $2.38 |
---|---|
Change Percent: | -3.36% |
Open: | $2.46 |
Close: | $2.38 |
High: | $2.46 |
Low: | $2.33 |
Volume: | 735,399 |
Last Trade Date Time: | 07/26/2024 03:00:00 am |
News | Cerus Corporation (NASDAQ:CERS)
Cerus Corporation (Nasdaq: CERS) announced today that its second quarter 2024 financial results will be released on Thursday, August 1, 2024, after the close of the stock market. The Company will host a conference call and webcast at 4:30 P.M. ET that afternoon, during which management will discu...
Cerus Corporation (Nasdaq: CERS) today announced the appointment of Dean Gregory to its Board of Directors. Mr. Gregory has a 30+-year career as a leader in the global blood transfusion and cell therapy industry, with broad experience across commercialization, product development, supply chain an...
Message Board Posts | Cerus Corporation (NASDAQ:CERS)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $CERS News Article - Cerus Corporation to Release Fourth Quarter and Full Year 2022 Fin | whytestocks | investorshangout | 02/15/2023 7:30:50 PM |
whytestocks: $CERS News Article - Cerus (CERS) Q1 2022 Earnings Call Transcript | whytestocks | investorshangout | 05/06/2022 2:45:50 PM |
AviseAnalytics: 4 STOCKS TO BUY FOR HIGHER RETURNS! Technology Industry has been focused on minimizi | AviseAnalytics | investorshangout | 01/06/2022 1:12:06 PM |
whytestocks: $CERS News Article - Cerus Corporation to Participate in Stephens Annual Investment Con | whytestocks | investorshangout | 11/19/2021 8:00:49 PM |
whytestocks: $CERS News Article - Cerus Corporation (CERS) Q3 2021 Earnings Call Transcript | whytestocks | investorshangout | 11/03/2021 2:30:53 PM |
News, Short Squeeze, Breakout and More Instantly...
Cerus Corporation (Nasdaq: CERS) announced today that its second quarter 2024 financial results will be released on Thursday, August 1, 2024, after the close of the stock market. The Company will host a conference call and webcast at 4:30 P.M. ET that afternoon, during which management will discu...
Cerus Corporation (Nasdaq: CERS) today announced the appointment of Dean Gregory to its Board of Directors. Mr. Gregory has a 30+-year career as a leader in the global blood transfusion and cell therapy industry, with broad experience across commercialization, product development, supply chain an...
Symposium and Abstracts Highlight Data from Real-world Implementation and Utilization of INTERCEPT Platelets and Plasma as well as from Red Blood Cell and LED Illuminator Programs Cerus Corporation (Nasdaq:CERS) today announced a lunch symposium and selection of abstracts at the 38 th...